Influence of phosphatidylcholine on ultrafiltration and solute transfer in CAPD patients

ASAIO Trans. 1990 Jul-Sep;36(3):M581-3.

Abstract

Fifteen patients (mean age 59.9 +/- 16.1 years) treated by CAPD for a mean of 21.6 +/- 14 months, underwent peritoneal clearances before and after 15 days of intraperitoneal phosphatidylcholine (PC) treatment (50 mg/L). No difference was observed in urea, creatinine, uric acid, and reverse dextrose clearances. A statistically significant increase in phosphate clearances (4 and 6 hr dwell times) (1.36%) and a reduction in drainage volume (2 hr dwell time) (1.36%) were observed after treatment. Urine output and percent dextrose reabsorption were unchanged. The ultrafiltration (UF) showed a tendency to increase, which lasted for 15 days after discontinuation of treatment. This tendency allowed the patients to reduce, during the same period, the amount of hypertonic solution (23.8 L vs. 21.3 L) required. The tendency to increase UF over time deserves further study.

MeSH terms

  • Adult
  • Aged
  • Blood Urea Nitrogen
  • Combined Modality Therapy
  • Creatinine / blood
  • Female
  • Humans
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Phosphates / blood
  • Phosphatidylcholines / administration & dosage*
  • Uric Acid / blood

Substances

  • Phosphates
  • Phosphatidylcholines
  • Uric Acid
  • Creatinine